Le Lézard
Classified in: Health, Business
Subjects: NPT, PER, HSP, DEI

DR. JENNIFER NUOVO APPOINTED CHIEF MEDICAL OFFICER FOR BLUE SHIELD OF CALIFORNIA PROMISE HEALTH PLAN


Experienced clinician and health care executive joins nonprofit health plan serving Medi-Cal members

LOS ANGELES, Oct. 16, 2023 /PRNewswire/ -- Jennifer A. Nuovo, M.D., has been named chief medical officer for Blue Shield of California Promise Health Plan, which provides health coverage for Medi-Cal beneficiaries in Los Angeles and San Diego counties.

As chief medical officer, Dr. Nuovo will lead clinical strategy development and implementation to support the health and wellbeing of the nonprofit managed care plan's more than 530,000 members. Additionally, she will work closely with the chief health equity officer of Blue Shield Promise to support its health equity strategy.

"Dr. Nuovo's passion for patient-centric care and deep knowledge of California's regulatory environment make her an ideal fit as our new chief medical officer," said Kristen Cerf, president and CEO of Blue Shield Promise. "Her expertise will further our ability to deliver holistic and high-quality care to the communities and members we serve."

Dr. Nuovo comes to Blue Shield Promise with an extensive record of accomplishments over a medical career spanning nearly four decades. Most recently, Dr. Nuovo served as the chief medical officer of UnitedHealthcare Community Plan of California, where she oversaw clinical and quality functions of a Medi-Cal managed care plan. Prior to that role, Dr. Nuovo served as the chief medical executive of Sutter Health Plan, a northern California-based commercial health maintenance organization.

Dr. Nuovo earned her Bachelor of Arts degree from Columbia University's Barnard College and her M.D. from the University of Vermont College of Medicine.

About Blue Shield of California Promise Health Plan
Blue Shield of California Promise Health Plan is a managed care organization, wholly owned by Blue Shield of California, offering Medi-Cal. It is led by healthcare professionals with a "members-first" philosophy and committed to building a quality network of providers and partnering with community organizations for more than 537,000 members across Los Angeles and San Diego counties. For more information about Blue Shield of California Promise Health Plan, please visit www.blueshieldca.com/promise. For more news about Blue Shield of California, please visit news.blueshieldca.com. Or follow us on LinkedInTwitter, or Facebook.

CONTACT:

Erika Conner


Blue Shield of California    


510-607-2359


[email protected] 

 

SOURCE Blue Shield of California Promise Health Plan


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: